A multicenter study led by Cedars-Sinai created a database of adverse medication eventsâthe fourth leading cause of death in the United States and a medical issue costing more than $500 billion annually.
Weâre pleased to announce Carolyn Mudry, D.O, has joined the Pascack Valley Medical Group family. With over 25 years of experience, Dr. Mudry brings a wealth of expertise in providing comprehensive, patient-centered care to the patients of Pascack Valley.
Atrial fibrillation (AFib) is the most common type of heart arrhythmia impacting more than 5 million people in the United States, a number that is anticipated to reach 12.1 million by 2030. The heart rhythm condition is characterized by fast and irregular heartbeats from the upper chambers of the heart. People with AFib are at increased risk of stroke, heart failure, dementia, and premature death.
Cedars-Sinai investigators have developed a novel artificial intelligence (AI) model, named DYNA, that accurately distinguishes harmful gene variations from harmless ones, potentially enhancing physiciansâ ability to diagnose diseases. The new tool could pave the way for more precise personalized medicine and targeted therapies.
Biomedical researchers at Washington University in St. Louis have decoded how mechanical forces drive cell behavior in fibrosis.
New Center Aims to Accelerate AI Research and Personalized Treatment in Childrenâs Health
Glioblastoma is one of the toughest cancers to treat, but a new study suggests that suppressing a protein (ZNF638) triggers an antiviral immune response, making immune checkpoint inhibitors more effective. The discovery also identifies ZNF638 as a biomarker that could help personalize immunotherapy.
20221027104337.jpg&width=400&height=400)
A new study led by Dr. Roy Herbst, deputy director of Yale Cancer Center, found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with lung cancer, years after their treatment.
A recent review has shed new light on the management of pediatric postural orthostatic tachycardia syndrome (POTS), a chronic condition causing dizziness, fatigue, and fainting, often triggered by standing. The study emphasizes the importance of personalized treatment strategies that focus on underlying mechanisms such as central hypovolemia, vascular dysfunction, and hyperadrenergic states. By tailoring therapies to the unique physiological and biochemical profiles of each patient, researchers are making strides in improving the outcomes for children affected by this challenging condition.
A recent study unveils how stromal interaction molecule 1 (STIM1), a protein involved in calcium signaling, plays a pivotal role in the resistance of liver cancer to sorafenib, a key treatment for advanced hepatocellular carcinoma (HCC).
A groundbreaking pharmacogenetic tool has been developed and validated to predict chemotherapy side effects based on a patientâs genetic profile.
A new Mount Sinai study provides compelling evidence that exercise can significantly help the mental well-being of millions of women living with chronic pelvic pain disorders (CPPDs), such as endometriosis and uterine fibroids. The researchers at the Icahn School of Medicine at Mount Sinai found that activities like brisk walking or aerobic exercise can lead to measurable improvements in mental well-being, regardless of pain levels or history of anxiety or depressive disorders. Their findings were reported in the February 26 online issue of the Journal of Pain Research.
A new artificial intelligence (AI) model has been developed to predict how long a person with a learning disability is likely to stay in hospital, offering valuable insights that could improve care and resource planning. Developed by computer scientists at Loughborough University as part of the âDECODEâ project, the model aims to tackle healthcare challenges faced by people with learning disabilities and multiple health conditions.
Migraine is much more than just a headache. It is a debilitating disease that can drastically impact the lives of those affected, limiting their ability to work, study, travel, spend time with family, and enjoy everyday moments.
Masimirembwa, a Distinguished Professor at Wits University's Sydney Brenner Institute for Molecular Bioscience (SBIMB), received the award at a ceremony in California, USA, on 7 February. The PMWC Pioneer Award recognises Masimirembwaâs groundbreaking work in pharmacogenomics, shedding light on how genetic differences influence drug responses across diverse populations.
Empa researchers have developed a new 3D tissue analysis for thyroid tumors. This special X-ray method uses artificial intelligence to enable more precise diagnoses without damaging the tissue removed. In the future, this examination method could also be used for other types of cancer and replace more complex procedures with simpler imaging methods.
Wesper, a leader in advanced home sleep apnea testing (HSAT), is transforming how obesity and sleep apnea are managed by integrating groundbreaking biometric sleep data with metabolic health innovations. Following the FDA approval of GLP-1 receptor agonists for sleep apnea treatment, Wesper is working with hospitals and physicians to bridge the gap between obesity, diabetes, GLP-1 medications, and sleep apnea.
The University of Texas MD Anderson Cancer Centerâs Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Andersonâs world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This issue includes studies to be presented this week at the 2025 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium.
A study explores how variations in the copy number of certain DNA segments can influence cognitive abilities and neurodevelopment.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right